Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Pavadi Capital LLC

Q4 2023 · 13F-HR

Pavadi Capital LLCholdings as filed

Filed 2024-02-14 · accession 0001420506-24-000341

$81.2M
Reported value
14
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
036752103ELVELEVANCE HEALTH INC$8.2M10.1%17,374CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$8.0M9.90%15,271CommonSOLE
40412C101HCAHCA HEALTHCARE INC$7.6M9.31%27,927CommonSOLE
60855R100MOHMOLINA HEALTHCARE INC$6.9M8.49%19,079CommonSOLE
15135B101CNCCENTENE CORP DEL$6.9M8.44%92,349CommonSOLE
126650100CVSCVS HEALTH CORP$6.8M8.32%85,580CommonSOLE
98956P102ZBHZIMMER BIOMET HOLDINGS INC$6.8M8.32%55,515CommonSOLE
444859102HUMHUMANA INC$6.4M7.83%13,878CommonSOLE
071813109BAXBAXTER INTL INC$5.1M6.25%131,315CommonSOLE
703395103PDCOEURPATTERSON COS INC$4.6M5.61%160,155CommonSOLE
36266G107GEHCGE HEALTHCARE TECHNOLOGIES I$4.4M5.39%56,560CommonSOLE
219798105QDELQUIDELORTHO CORP$3.7M4.61%50,752CommonSOLE
88033G407THCTENET HEALTHCARE CORP$3.5M4.32%46,433CommonSOLE
516544103LNTHLANTHEUS HLDGS INC$2.5M3.09%40,492CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.